Until Epic 2019 Go-live
- 08.10.2019 12:01-5am FULL DOWNTIME
- In-house and HI regional “Command center”
- Superuser RNs on each floor
- Dedicated phone line for physicians
- Epic still accessible via READ-ONLY environment
Major new features Epic 2019Continue reading “August 2019 Epic Upgrade – Special Newsletters (#1, #2, #3)”
Holding Antithrombotics Around Regional Anesthesia:
You’ll hear about appropriate use of antithrombotics around epidurals or spinals due to updated regional anesthesia guidelines.
Spinal or epidural hematomas from regional anesthesia are rare but can lead to paralysis. Hematoma risk goes up when antithrombotics are given around the time of catheter insertion or removal.
Consider the following strategies, along with patient and operative risks when making decisions on the use of anticoagulants around regional anesthesia.Continue reading “📖 – Pharmacy Newsletter February 2019”
New Tetracyclines Recently Approved by the FDA:
Omadacycline (Nuzyra) is a new tetracycline approved for treating community acquired pneumonia (CAP) and skin infections (including MRSA). In clinical trials omadacycline was shown to be non-inferior to moxifloxacin for CAP or linezolid for skin infections.Continue reading “📖 – Pharmacy Newsletter January 2019”